nCounter® PanCancer Progression Panel

Perform multiplex gene expression analysis with 770 genes from each step in the cancer progression process including: angiogenesis, extracellular matrix remodeling (ECM), epithelial-to-mesenchymal transition (EMT) and metastasis.

  • Comprehensive gene expression analysis of cancer progression
  • Quantify gene expression of metastatic growth and suppressor genes
  • Rapidly and easily screen samples for biomarker discovery or drug mechanism of action to support your research
  • Customizable with up to 30 additional user-defined genes with Panel Plus option
  • 3D-enabled for multi-analyte analysis with Vantage 3D™ Assays

The following is a pictorial description of the processes and key genes included in the PanCancer Progression Panel

T

Feature

Specifications

Number of Targets

770 including 30 PanCancer reference genes

Input Material

25 ng–300 ng

Sample Type(s)

FFPE-derived RNA, total RNA, fragmented RNA, cell lysates

Species

Human

Single Cell/Low Input Material Protocol

Yes

Customizable

Yes

Time to Results

Approximately 24 hours

Data Analysis

nSolver™ Analysis software

Shipping and Storage Conditions

-80°C

Product

Description

Catalog Number

NAV Number

Unit Size

nCounter® PanCancer Progression Panel (CodeSet Only)

Gene Expression CodeSet profiling (770 genes). 740 cancer-related human genes plus 30 internal reference controls. Master Kit reagents sold separately.

XT-CSO-PROG1-12

115000152

12 reactions

Click here to view publications.

For Research Use Only. Not for use in diagnostic procedures.